• This record comes from PubMed

Resistin levels in perivascular adipose tissue and mid-term mortality in patients undergoing coronary artery bypass grafting

. 2021 Aug 31 ; 70 (4) : 543-550. [epub] 20210601

Language English Country Czech Republic Media print-electronic

Document type Journal Article

Higher serum resistin levels were reported to be associated with increased mortality risk. We aimed to assess the predictive value of resistin levels in perivascular adipose tissue (PVAT) around the left main coronary artery (LMCA) for mid-term survival of patients with advanced coronary artery disease (CAD).This was a prospective study including patients referred for elective coronary artery grafting in 2016 and 2017, performed using a standard approach. A sample of PVAT was harvested and resistin levels were measured using an enzyme-linked immunosorbent assay. Patients were followed from the day of the procedure until March 2021. In each patient, the SYNTAX score and EuroSCORE II were calculated. The study included 108 patients aged 68.1 ±7.9 years, including 83 men (76.9%). The duration of follow-up was 731 (range, 275-1020) for nonsurvivors and 1418 median (range, 1174-1559) for survivors (p <0.001). Patients who died had a higher SYNTAX score, higher EuroSCORE II, and lower resistin levels in PVAT than survivors (p <0.001, p = 0.004, and p = 0.041, respectively). A stepwise regression analysis revealed that survival was related to resistin concentrations above the median value (hazard ratio [HR], 4.67; 95% CI, 1.02-21.4; p = 0.048) and EuroSCORE II (used as continuous variable; HR, 1.55; 95% CI, 1.16-2.07; p = 0.003). The mid-term mortality in patients with advanced CAD is associated with low resistin concentrations in PVAT surrounding the LMCA.

See more in PubMed

AL-NIMER MS, ALHUSSEINY AH, IBRAHIM AK. Assessment of serum adiponectin and leptin levels in patients with ischaemic heart disease: an association with the ejection fraction, coronary calcium score and coronary. Folia Cardiologica. 2018;13:204–209. doi: 10.5603/FC.2018.0041. DOI

ANTONIADES C, KOTANIDIS CP, BERMAN DS. State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue? J Cardiovasc Comput Tomogr. 2019;13:288–296. doi: 10.1016/j.jcct.2019.03.006. PubMed DOI PMC

ANTONOPOULOS AS, MARGARITIS M, COUTINHO P, DIGBY J, PATEL R, PSARROS C, NTUSI N, KARAMITSOS TD, LEE R, DE SILVA R, PETROU M, SAYEED R, DEMOSTHENOUS M, BAKOGIANNIS C, WORDSWORTH PB, TOUSOULIS D, NEUBAUER S, CHANNON KM, ANTONIADES C. Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 2014;34:2151–2159. doi: 10.1161/ATVBAHA.114.303828. PubMed DOI

ANTONOPOULOS AS, SANNA F, SABHARWAL N, THOMAS S, OIKONOMOU EK, HERDMAN L, MARGARITIS M, SHIRODARIA C, KAMPOLI AM, AKOUMIANAKIS I, PETROU M, SAYEED R, KRASOPOULOS G, PSARROS C, CICCONE P, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9 doi: 10.1126/scitranslmed.aal2658. PubMed DOI

BOS D, SHAHZAD R, VAN WALSUM T, VAN VLIET LJ, FRANCO OH, HOFMAN A, NIESSEN WJ, VERNOOIJ MW, VAN DER LUGT A. Epicardial fat volume is related to atherosclerotic calcification in multiple vessel beds. Eur Heart J Cardiovasc Imaging. 2015;16:1264–1269. doi: 10.1093/ehjci/jev086. PubMed DOI

CARBONE S, CANADA JM, BILLINGSLEY HE, SIDDIQUI MS, ELAGIZI A, LAVIE CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100. doi: 10.1016/j.pcad.2019.08.004. PubMed DOI PMC

DEY D, NAKAZATO R, LI D, BERMAN DS. Epicardial and thoracic fat: noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012;2:85–93. PubMed PMC

ELAGIZI A, KACHUR S, LAVIE CJ, CARBONE S, PANDEY A, ORTEGA FB, MILANI RV. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61:142–150. doi: 10.1016/j.pcad.2018.07.003. PubMed DOI

FONTANA A, SPADARO S, COPETTI M, SPOTO B, SALVEMINI L, PIZZINI P, PIZZINI P, FRITTITTA L, MALLAMACI F, PELLEGRINI F, TRISCHITTA V, MENZAGHI C. Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis. PLoS One. 2015;10:e0120419. doi: 10.1371/journal.pone.0120419. PubMed DOI PMC

FRANSSENS BT, NATHOE HM, VISSEREN FL, VAN DER GRAAF Y, LEINER T SMART Study Group. Relation of epicardial adipose tissue radiodensity to coronary artery calcium on cardiac computed tomography in patients at high risk for cardiovascular disease. Am J Cardiol. 2017;119:1359–1365. doi: 10.1016/j.amjcard.2017.01.031. PubMed DOI

HORWICH TB, FONAROW GC, CLARK AL. obesity and obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151–156. doi: 10.1016/j.pcad.2018.05.005. PubMed DOI

ITO T, SUZUKI Y, EHARA M, MATSUO H, TERAMOTO T, TERASHIMA M, et al. Impact of epicardial fat volume on coronary artery disease in symptomatic patients with a zero calcium score. Int J Cardiol. 2013;167:2852–2858. doi: 10.1016/j.ijcard.2012.07.026. PubMed DOI

KRECKI R, DROZDZ J, SZCZEŚNIAK P, ORSZULAK-MICHALAK D, KRZEMIŃSKA-PAKUŁA M. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease. Kardiol Pol. 2008;66:1173–1180. PubMed

LAFRAMBOISE WA, DHIR R, KELLY LA, PETROSKO P, KRILL-BURGER JM, SCIULLI CM, LYONS-WEILER MA, CHANDRAN UR, LOMAKIN A, MASTERSON RV, MARROQUIN OC, MULUKUTLA SR, MCNAMARA DM. Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med. 2012;10:157–160. doi: 10.1186/1741-7015-10-157. PubMed DOI PMC

LUBOS E, MESSOW CM, SCHNABEL R, RUPPRECHT HJ, ESPINOLA-KLEIN C, BICKEL C, PEETZ D, POST F, LACKNER KJ, TIRET L, MÜNZEL T, BLANKENBERG S. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis. 2007;193:121–128. doi: 10.1016/j.atherosclerosis.2006.05.039. PubMed DOI

MANCIO J, OIKONOMOU EK, ANTONIADES C. Perivascular adipose tissue and coronary atherosclerosis. Heart. 2018;104:1654–1662. doi: 10.1136/heartjnl-2017-312324. PubMed DOI

NASHEF SA, ROQUES F, SHARPLES LD, NILSSON J, SMITH C, GOLDSTONE AR, LOCKOWANDT U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–744. doi: 10.1093/ejcts/ezs043. PubMed DOI

NOSALSKI R, GUZIK TJ. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol. 2017;174:3496–3513. doi: 10.1111/bph.13705. PubMed DOI PMC

OIKONOMOU EK, MARWAN M, DESAI MY, MANCIO J, ALASHI A, HUTT CENTENO E, THOMAS S, HERDMAN L, KOTANIDIS CP, THOMAS KE, GRIFFIN BP, FLAMM SD, ANTONOPOULOS AS, SHIRODARIA C, SABHARWAL N, DEANFIELD J, NEUBAUER S, HOPEWELL JC, CHANNON KM, ACHENBACH S, ANTONIADES C. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392:929–939. doi: 10.1016/S0140-6736(18)31114-0. PubMed DOI PMC

PILZ S, WEIHRAUCH G, SEELHORST U, WELLNITZ B, WINKELMANN BR, BOEHM BO, MÄRZ W. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol (Oxf) 2007;66:380–386. doi: 10.1111/j.1365-2265.2007.02743.x. PubMed DOI

SARACEVIC A, 1, MEDVED I, HRABRIC VLAHS, KOZMAR A, BILIC-ZULLE L, SIMUNDIC AM. The association of systemic inflammatory markers with indicators of stress and cardiac necrosis in patients undergoing aortic valve replacement and revascularization surgeries. Physiol Res. 2020;69:261–274. doi: 10.33549/physiolres.934243. PubMed DOI PMC

SPILIOPOULOS K, BAGIATIS V, DEUTSCH O, KEMKES BM, ANTONOPOULOS N, KARANGELIS D, HASCHEMI A. Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement. Gen Thorac Cardiovasc Sur. 2014;62:103–111. doi: 10.1007/s11748-013-0311-8. PubMed DOI

SULLIVAN PG, WALLACH JD, IOANNIDIS JP. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery. Am J Cardiol. 2016;118:1574–1582. doi: 10.1016/j.amjcard.2016.08.024. PubMed DOI

VERSTEYLEN MO, TAKX RA, JOOSEN IA, NELEMANS PJ, DAS M, CRIJNS HJ, HOFSTRA L, LEINER T. Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain. Eur Heart J Cardiovasc Imaging. 2012;13:517–523. doi: 10.1093/ehjci/jes024. PubMed DOI

WANG H, CHEN DY, CAO J, HE ZY, ZHU BP, LONG M. High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin Med Sci J. 2009;24:161–166. doi: 10.1016/S1001-9294(09)60082-1. PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...